
Jeffrey S. Parkin
Examiner (ID: 2776)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1641, 1813, 1671 |
| Total Applications | 1731 |
| Issued Applications | 935 |
| Pending Applications | 260 |
| Abandoned Applications | 571 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6234916
[patent_doc_number] => 20100266620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'Immunoconjugates for treatment of infectious diseases'
[patent_app_type] => utility
[patent_app_number] => 11/655266
[patent_app_country] => US
[patent_app_date] => 2007-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8030
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20100266620.pdf
[firstpage_image] =>[orig_patent_app_number] => 11655266
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/655266 | Immunoconjugates for treatment of infectious diseases | Jan 18, 2007 | Abandoned |
Array
(
[id] => 6275106
[patent_doc_number] => 20100256040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION'
[patent_app_type] => utility
[patent_app_number] => 11/625200
[patent_app_country] => US
[patent_app_date] => 2007-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 44586
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20100256040.pdf
[firstpage_image] =>[orig_patent_app_number] => 11625200
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/625200 | COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION | Jan 18, 2007 | Abandoned |
Array
(
[id] => 5259646
[patent_doc_number] => 20070213278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Arrays with cleavable linkers'
[patent_app_type] => utility
[patent_app_number] => 11/645273
[patent_app_country] => US
[patent_app_date] => 2006-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 33089
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20070213278.pdf
[firstpage_image] =>[orig_patent_app_number] => 11645273
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/645273 | Arrays with cleavable linkers | Dec 21, 2006 | Abandoned |
Array
(
[id] => 5135999
[patent_doc_number] => 20070077628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases'
[patent_app_type] => utility
[patent_app_number] => 10/568707
[patent_app_country] => US
[patent_app_date] => 2006-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 24911
[patent_no_of_claims] => 89
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077628.pdf
[firstpage_image] =>[orig_patent_app_number] => 10568707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/568707 | Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases | Dec 13, 2006 | Abandoned |
Array
(
[id] => 6392321
[patent_doc_number] => 20100303848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'VACCINATION METHOD'
[patent_app_type] => utility
[patent_app_number] => 12/086350
[patent_app_country] => US
[patent_app_date] => 2006-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 2132
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303848.pdf
[firstpage_image] =>[orig_patent_app_number] => 12086350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/086350 | VACCINATION METHOD | Dec 12, 2006 | Abandoned |
Array
(
[id] => 4764625
[patent_doc_number] => 20080175836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Immunogenic composition based on conditionally live virion and method for producing the same'
[patent_app_type] => utility
[patent_app_number] => 11/634508
[patent_app_country] => US
[patent_app_date] => 2006-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22357
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20080175836.pdf
[firstpage_image] =>[orig_patent_app_number] => 11634508
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/634508 | Immunogenic composition based on conditionally live virion and method for producing the same | Dec 5, 2006 | Abandoned |
Array
(
[id] => 7689479
[patent_doc_number] => 20070105219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Retrovirus from the HIV group and its use'
[patent_app_type] => utility
[patent_app_number] => 11/634254
[patent_app_country] => US
[patent_app_date] => 2006-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11679
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105219.pdf
[firstpage_image] =>[orig_patent_app_number] => 11634254
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/634254 | Retrovirus from the HIV group and its use | Dec 5, 2006 | Abandoned |
Array
(
[id] => 5045954
[patent_doc_number] => 20070264627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Retrovirus from the HIV group and its use'
[patent_app_type] => utility
[patent_app_number] => 11/634155
[patent_app_country] => US
[patent_app_date] => 2006-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11676
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11634155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/634155 | Retrovirus from the HIV group and its use | Dec 5, 2006 | Abandoned |
Array
(
[id] => 6392413
[patent_doc_number] => 20100303858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-02
[patent_title] => 'Chimeric HIV-1 Glycoproteins and Their Biological Applications'
[patent_app_type] => utility
[patent_app_number] => 12/085632
[patent_app_country] => US
[patent_app_date] => 2006-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 9153
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0303/20100303858.pdf
[firstpage_image] =>[orig_patent_app_number] => 12085632
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/085632 | Chimeric HIV-1 Glycoproteins and Their Biological Applications | Nov 27, 2006 | Abandoned |
Array
(
[id] => 4988578
[patent_doc_number] => 20070154917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Compositions and method for treating viral infections'
[patent_app_type] => utility
[patent_app_number] => 11/605017
[patent_app_country] => US
[patent_app_date] => 2006-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25952
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20070154917.pdf
[firstpage_image] =>[orig_patent_app_number] => 11605017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/605017 | Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes | Nov 27, 2006 | Issued |
Array
(
[id] => 5374629
[patent_doc_number] => 20090312190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses'
[patent_app_type] => utility
[patent_app_number] => 12/094503
[patent_app_country] => US
[patent_app_date] => 2006-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18030
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312190.pdf
[firstpage_image] =>[orig_patent_app_number] => 12094503
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/094503 | Methods and Proteins for the Prophylactic and/or Therapeutic Treatment of Four Serotypes of Dengue Virus and Other Flaviviruses | Nov 20, 2006 | Abandoned |
Array
(
[id] => 5539136
[patent_doc_number] => 20090220941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'COMPOSITIONS FOR- DETECTING OF INFLUENZA VIRUSES AND KITS AND METHODS USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/091665
[patent_app_country] => US
[patent_app_date] => 2006-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14228
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220941.pdf
[firstpage_image] =>[orig_patent_app_number] => 12091665
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/091665 | COMPOSITIONS FOR- DETECTING OF INFLUENZA VIRUSES AND KITS AND METHODS USING SAME | Oct 24, 2006 | Abandoned |
Array
(
[id] => 6054617
[patent_doc_number] => 20110110977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'Multiclade HIV Vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/083905
[patent_app_country] => US
[patent_app_date] => 2006-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21115
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110977.pdf
[firstpage_image] =>[orig_patent_app_number] => 12083905
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/083905 | Multiclade HIV Vaccines | Oct 16, 2006 | Abandoned |
Array
(
[id] => 7502327
[patent_doc_number] => 08034355
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-10-11
[patent_title] => 'Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase'
[patent_app_type] => utility
[patent_app_number] => 12/089353
[patent_app_country] => US
[patent_app_date] => 2006-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14392
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/034/08034355.pdf
[firstpage_image] =>[orig_patent_app_number] => 12089353
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/089353 | Attenuated nonsegmented negative-sense RNA viruses with reduced mRNA cap methyltransferase activity comprising mutations within conserved domain VI of the large polymerase | Oct 5, 2006 | Issued |
Array
(
[id] => 5193527
[patent_doc_number] => 20070082011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Recombinant proteins from filoviruses and their use'
[patent_app_type] => utility
[patent_app_number] => 11/545093
[patent_app_country] => US
[patent_app_date] => 2006-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19857
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082011.pdf
[firstpage_image] =>[orig_patent_app_number] => 11545093
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/545093 | Drosophila cell lines producing recombinant secretable filovirus surface glycoproteins lacking the membrane spanning domain | Oct 4, 2006 | Issued |
Array
(
[id] => 5204503
[patent_doc_number] => 20070025983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Compounds capable of inhibiting HIV-1 infection'
[patent_app_type] => utility
[patent_app_number] => 11/544346
[patent_app_country] => US
[patent_app_date] => 2006-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9115
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20070025983.pdf
[firstpage_image] =>[orig_patent_app_number] => 11544346
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/544346 | Compounds capable of inhibiting HIV-1 infection | Oct 4, 2006 | Issued |
Array
(
[id] => 5952341
[patent_doc_number] => 20110033446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'Treatment of HIV-1-infected individuals to reduce risk of coronary artery disease and suppress virus replication'
[patent_app_type] => utility
[patent_app_number] => 11/528431
[patent_app_country] => US
[patent_app_date] => 2006-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12719
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033446.pdf
[firstpage_image] =>[orig_patent_app_number] => 11528431
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/528431 | Method of suppressing human immunodeficiency virus (HIV) replication in a subject by administering a liver X receptor (LXR) agonist | Sep 27, 2006 | Issued |
Array
(
[id] => 5004559
[patent_doc_number] => 20070202127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-30
[patent_title] => 'Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids'
[patent_app_type] => utility
[patent_app_number] => 11/529806
[patent_app_country] => US
[patent_app_date] => 2006-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 84
[patent_figures_cnt] => 84
[patent_no_of_words] => 37619
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20070202127.pdf
[firstpage_image] =>[orig_patent_app_number] => 11529806
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/529806 | Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids | Sep 27, 2006 | Abandoned |
Array
(
[id] => 5241788
[patent_doc_number] => 20070020280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Compositions and methods for inhibition of HIV-1 infection'
[patent_app_type] => utility
[patent_app_number] => 11/520556
[patent_app_country] => US
[patent_app_date] => 2006-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 21986
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20070020280.pdf
[firstpage_image] =>[orig_patent_app_number] => 11520556
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/520556 | Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors | Sep 11, 2006 | Issued |
Array
(
[id] => 5101763
[patent_doc_number] => 20070185025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-09
[patent_title] => 'Filoviral immunosuppressive peptides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/518641
[patent_app_country] => US
[patent_app_date] => 2006-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 29001
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20070185025.pdf
[firstpage_image] =>[orig_patent_app_number] => 11518641
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/518641 | Filoviral immunosuppressive peptides and uses thereof | Sep 10, 2006 | Abandoned |